Biophytis S.A. (BPTSY)
OTCMKTS
· Delayed Price · Currency is USD
2.770
0.00 (0.00%)
Jan 31, 2025, 4:00 PM EST
Biophytis Employees
Biophytis had 22 employees as of December 31, 2023. The number of employees decreased by 2 or -8.33% compared to the previous year.
Employees
22
Change (1Y)
-2
Growth (1Y)
-8.33%
Revenue / Employee
n/a
Profits / Employee
-$734,150
Market Cap
4.94M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Endo Inc. | 2,931 |
Elite Pharmaceuticals | 64 |
Glass House Brands | 413 |
Northwest Biotherapeutics | 25 |
Silence Therapeutics | 109 |
CytoDyn | 9 |
SANUWAVE Health | 31 |
Biophytis News
- 5 days ago - Biophytis Announces Its Participation to the BIOMED FORUM Investor Conference - Newsfile Corp
- 11 days ago - Biophytis and AskHelpU Sign a Co-Development Agreement in Rare Neuromuscular Diseases in China - Newsfile Corp
- 18 days ago - Biophytis Enters Exclusive Negotiations with a Chinese Pharmaceutical Company to License BIO101 - Newsfile Corp
- 4 months ago - Biophytis Publishes First-Half Financial Results and Provides an Update on its Business Activities - Accesswire
- 6 months ago - Biophytis Deploys its Partnership Strategy and Signs Two Contracts with Local Agents in Asia - Accesswire
- 7 months ago - Biophytis Obtains IND Approval from the FDA to Start its Phase 2 OBA Study in Obesity - Accesswire
- 7 months ago - Biophytis Presented its Phase 2-3 COVA Study Results in Severe Forms of Covid-19 at the WCID in Paris - Accesswire
- 8 months ago - Biophytis grants Blanver Exclusive Rights to BIO101 in Latin America in Deal Valued at up to €108 Million - Accesswire